stars 1 stars 2 stars 3

BCO Pharma is a late development stage healthcare company that develops products for the unique needs of pediatric or other vulnerable patient populations. The company's lead product is a unique pediatric formulation of an inotrope that is used to treat hypotension in critically ill babies and children. The phase III trial supporting the product is now finished and an application for a marketing authorization in the EU will be submitted in August of 2022.

BCO Pharma Questions

The BCO Pharma annual revenue was $1 million in 2026.

Seamus O'Loan is the CEO of BCO Pharma.

1 people are employed at BCO Pharma.

BCO Pharma is based in Cork, Munster.

The NAICS codes for BCO Pharma are [32541, 325, 32, 3254].

The SIC codes for BCO Pharma are [283, 28].

Top BCO Pharma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users